ABSTRACT Coccidiosis is a costly parasitic disease to the poultry industry with multiple prevention methods being explored to control its impact. This study evaluated the feeding effects of β-glucans on performance and responses of chickens during a coccidiosis challenge. Cobb 500 male broilers (n = 1280) were assigned to 1 of 8 treatment groups (8 replicate pens; 20 birds/pen) in a 2 × 4 factorial arrangement, including non-infected and Eimeria-infected birds fed for 28 d a control diet, control + BG (150 g/MT Algamune 50), control + BGZn (100 g/MT Algamune 50 Zn), and control + 0.01% Salinomycin (Sal). On d15, birds in the challenge groups received a mixed Eimeria inoculum. Birds and feed were weighed weekly on a per pen basis to evaluate body weight gain (BWG), feed intake (FI), and feed conversion ratios (FCR). Lesion scores were assessed 6 d post infection (d21) on 3 birds per pen. Performance data were subjected to ANOVA and differences were established using the LS-MEANS statement with significance reported at P ≤ 0.05. There were minor differences in lesion scores among the dietary treatments in the infected groups with reduced duodenal and cecal scores in the Sal group compared to the BGZn and BG groups, respectively. The coccidiosis challenge main effect resulted in a significant reduction in 0-28 d BW and FI. Dietary treatment resulted in non-significant effect on BWG, but Sal addition resulted in increased FI. A significant diet X challenge interaction resulted in higher FCR in the Eimeria-challenged birds supplemented with Sal and BGZn in comparison to the other challenged groups, likely due to reduced mortality in the challenged Sal and BGZn groups. Body composition analysis at d28 revealed that the Eimeria challenge reduced both fat and lean tissue contents, where the β-glucans and Sal birds had lower fat percent than control birds.
INTRODUCTION
Coccidiosis is a parasitic disease of poultry that inflicts millions of dollars in damage to the world poultry industry every year and is widely regarded as one of the biggest threats to commercial operations. This disease is caused by the apicomplexan parasites of the genus Eimeria and can result in impaired growth and feed utilization (Shirley et al., 2007) . Currently, there are seven different species of Eimeria that invade different sections of the gastrointestinal (GI) tract of poultry causing considerable damage to the epithelial layer (McDougald, 2003) . The effects of the damage can vary from local destruction of the mucosal barrier and other tissues to systemic effects, and in more severe cases, can lead to death (Vermeulen et al., 2001; Ritzi et al., 2016) . Although commercial broilers are not usually vaccinated against coccidiosis, there is an urgent need C 2018 Poultry Science Association Inc. Received January 8, 2018. Accepted April 2, 2018. 1 Corresponding author: RDalloul@vt.edu to develop new treatments that will adequately protect against various infections while also avoiding adverse effects on performance. Anticoccidials have long been employed at sub-therapeutic levels to combat coccidiosis and other infections, provide better overall health, and enhance performance. Due to the recent ban of antibiotics and stricter standards being implemented, alternative prevention methods are being sought after to provide an effective product for use within animal production for commercial retail operations. The costs of veterinary and prophylactic treatment, as well as decreased production efficiency, are all key factors that can lead to increased prices for consumers (Shirley et al., 2007) . As such, the poultry industry is under increasing pressure to reduce the use of anticoccidials in commercial production, leading to more investigations of compounds capable of enhancing gut health and immune function.
β-glucans have been receiving increasing attention as potential alternatives due to their immunomodulatory ability without negatively affecting performance of the birds (Cox et al., 2010b) . β-glucans are carbohydrates, which form the structure of many cell walls 2713 of yeast, fungi, algae, and cereal grains (Vetvicka and Vetvickova, 2015) . β-glucans are composed of repeating D-glucose units joined together by glycosidic bonds in various conformations, resulting in either branched or linear structures (Vetvicka et al., 2014) . Because there is extensive variation in the structure of β-glucans based on their origin, their effectiveness in modulating the immune system can vary (Eccles, 2005) . It is generally accepted that 1,3/1,6-β-glucans, which are derived from yeast and fungi are considered to be the most effective form available due to their complex network of carbohydrate branching (Vetvicka and Vetvickova, 2007) . Linear forms derived from algae and seaweed have traditionally generated more research interest due to their high bioavailability and ease of production compared to branched β-glucans. β-glucans also act as prebiotics, described as carbohydrates that are not digestible by most monogastric animals and stimulate growth of commensal bacteria in the GI tract, thus contributing to gut health and the overall wellbeing of the animal (Gibson and Roberfroid, 1995) . This is particularly important because a healthier gut not only helps reduce the effects of enteric diseases, but also increases performance of the birds due to increased feed utilization and ultimately better feed conversion (Kabir et al., 2004; Tian et al., 2016) .
The effects of β-glucans in animal studies are well noted, but currently, there is limited research concerning the efficacy of β-glucans as immunomodulators in poultry. It is hypothesized that birds supplemented with β-glucans during coccidiosis will exhibit similar performance to non-challenged birds as measured by body weight gain and feed conversion ratios. The objective of this study was to evaluate the feeding effects of β-glucans with or without zinc on performance and responses of broiler chickens during a coccidiosis challenge.
MATERIALS AND METHODS

Birds and Experimental Treatments
The 28-day trial was conducted at the Virginia Tech Turkey Research Center (Blacksburg, VA) in floor pens set up with fresh, clean wood shavings. On day of hatch (DOH), 1280 Cobb male broiler chicks were assigned to 1 of 8 treatment groups and housed with 20 birds per pen and 8 replicate pens per treatment. Birds were counted, weighed, and separated for equal weight distribution across pens. The non-challenged groups were separated from the challenged pens by a buffer zone where personal protective equipment was changed to prevent cross-contamination. They were then assigned to the following treatment groups in a 2 × 4 factorial arrangement: non-infected and Eimeria-infected control, non-infected and Eimeria-infected control + β-glucan [BG] (150 g/MT Algamune AM, Algal Scientific, Plymouth, MI), non-infected and Eimeria-infected control + β-glucan with Zinc [BGZn] (100 g/MT 
Eimeria Challenge
On d 15, birds in the Eimeria-infected groups were challenged via oral gavage with a mixed inoculum of Eimeria oocysts. Each bird received 1 mL of inoculum containing 50,000 Eimeria acervulina, 10,000 E. maxima, and 5000 E. tenella sporulated oocysts (USDA-ARS, Beltsville, MD). On d 21, one bird per pen from the non-infected groups and three birds per pen from the Eimeria-infected groups were randomly selected and euthanized for lesion scoring associated with the Eimeria challenge. Three sections of the intestine (duodenum, jejunum, and cecum) were assessed using the standard Johnson and Reid (1970) method with scores range of 0 (no gross lesions) to 4 (most severe lesions). Excreta samples were collected from each pen on d 5-9 post Eimeria inoculation. Samples were stored in airtight plastic bags at 4
• C until assessed for oocyst counts. The samples were pooled by pen, diluted, and oocysts counted microscopically using a McMaster counting chamber (JA Whitlock & Co., Eastwood, NSW, Australia), then expressed as oocysts per gram of excreta.
Performance Measurements
Birds and feed weights were taken on DOH, d 14, d 21, and d 28. Body weight (BW), body weight gain (BWG), feed intake (FI), and mortality-corrected feed conversion ratio (FCR) were determined on a per pen basis, and then averaged by treatment.
Dual Energy X-Ray Absorptiometry (DXA)
On d 28, three birds per pen were randomly selected and euthanized for DXA analysis. These birds were wing-banded, weighed, defeathered and immediately frozen at -20
• C until DXA analysis. The birds were thawed and 10 birds were scanned at a time using GE Healthcare Lunar Prodigy Advance, System ID PA+130,744 (General Electric, Madison, WI) with duplicate measures taken. Body fat percentage, fat tissue, and lean tissue were measured using software version 9.30 (GE), and abdominal fat pads were removed and weighed post-DXA scan as a supplemental performance parameter. Each parameter measurement was averaged by treatment.
Statistical Analysis
Data were analyzed in a 2 × 4 factorial arrangement using SAS 9.3 (SAS Institute Inc., Cary, NC) statistical package and significant differences were established using the LS-MEANS statement with significance reported at P ≤ 0.05.
RESULTS
Body Weight (BW)
As presented in Figure 1 -A, there was a significant interaction between Eimeria challenge and β-glucan supplementation on d 21 BW (P = 0.0472), during the challenge first week. The non-challenged birds had significantly higher BW than the challenged birds, with the no additive-control birds weighing the most. There was a significant effect of Eimeria challenge on BW over these 7 days (P = 0.0012; 0.83 vs. 0.87 kg/bird). A significant interaction between Eimeria challenge and β-glucan supplementation was noted on d 28 (P < 0.0001) as presented in Figure 1 -B. The non-challenged birds had significantly higher BW on d 28 than the Eimeria challenged birds (P < 0.0001; 1.47 vs. 1.25 kg/bird). Average BW of the non-challenged and challenged birds did not differ significantly from no additive control groups on d 21 and d 28.
Body Weight Gain (BWG)
There was a significant effect of Eimeria challenge on average BWG from d 14 to d 21 (P < 0.0001), and a significant interaction was noted between Figure 2 -B presents average BWG from d 21 to d 28 with a significant interaction found between β-glucan supplementation and Eimeria challenge (P < 0.0001), as well as a significant effect of the Eimeria challenge noted during these 7 days (P < 0.0001; 0.42 vs. 0.60 kg/bird). The challenged BGZn and Sal birds exhibited higher BWG than control birds but no differences observed between both BG groups and Sal. Figure 2 -C shows average BWG from DOH to d 28 where significant interactions found between β-glucan supplementation and Eimeria challenge (P < 0.0001). The control group had the lowest overall BWG in the challenge setting, while the no-challenge control had the highest average BWG of all the treatment groups. The SAL, BG and BGZn groups performed similarly in both the challenge and no-challenge settings. A significant effect of the coccidiosis challenge was observed (P < 0.0001) resulting in lower BWG (1.21 kg/bird) in the Eimeria-challenged groups compared to the nonchallenged groups (1.43 kg/bird).
Feed Intake (FI)
No significant interaction was found between β-glucan supplementation and Eimeria challenge Figure 3 -A). However, there was a significant effect of Eimeria challenge on average FI over these 7 days (P = 0.0294). On average, the no-challenge treatments had higher FI than the Eimeria-challenged treatments, (88.67 vs. 85.00 g/bird/day). Presented in Figure 3 -B is average FI from d 21 to d 28. A significant interaction was observed between β-glucan supplementation and Eimeria challenge (P < 0.0001). The challenged Sal birds consumed more feed than the control birds but no other differences were observed otherwise. There was, however, a significant effect of Eimeria-challenge resulting in lower FI in the challenged birds (P < 0.0001; 104.83 vs.137.79 g/bird/day). Figure 3C presents average FI from DOH to d 28, and significant interaction between β-glucan supplementation and Eimeria challenge (P < 0.0001). A significant effect of Eimeria-challenge was noted (P < 0.0001), resulting in lower FI (66.08 g/bird/day) in the Eimeria-challenged groups compared to the nonchallenged groups (75.16 g/bird/day) for the 28 day study.
Feed Conversion Ratio (FCR)
A significant interaction effect was noted between β-glucan supplementation and Eimeria challenge on average FCR from d 14 to d 21 (P = 0.0003, Figure 4-A) . While not significant, the non-challenged control and BG groups had lower FCR than non-challenged BGZn and Sal treated birds, on average in the 6 days immediately following challenge. There was also a significant effect of Eimeria challenge (P < 0.0001), with nonchallenged birds having lower FCR (1.44) than challenged birds (1.56). Figure 4 -B shows average FCR from Figure 4 -C with a significant interaction noted between β-glucan supplementation and Eimeria challenge (P = 0.0095), as well as a significant effect of Eimeria challenge on average FCR for the 28 day study (P < 0.0001; 1.54 vs. 1.48). The non-challenged BG group had the lowest FCR, which was comparable to the control and better than the BGZn and Sal without challenge. 
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Mortality
As presented in Figure 5 , no significant interaction was noted between β-glucan supplementation on average mortality during the Eimeria challenge (d 15-21; P = 0.1761). However, there was a significant effect of the Eimeria challenge (P = 0.0258) resulting in higher mortality rates in the BG and Sal groups, but lower rates in the control and BGZn groups. The BG and Sal groups had the lowest mortality among the nonchallenged treatments, in comparison to the BGZn and control groups.
Lesion Scores
Day 21 duodenal lesion scores caused by E. acervulina are presented in Figure 6 -A. There was a significant effect of treatment (P < 0.0001), with Sal treatment generally having lower scores among the Eimeria challenged treatment groups. The highest scores were observed in the BGZn, which were not significantly different from the control and BG treatments. Figure 6 -B presents lesion scores in the jejunum on d 21. There was a significant difference among the Eimeria challenged and non-challenged treatment groups in the jejunum (P < 0.0001), but not between the challenged birds. The lesion scores in the ceca, the site of E. tenella infection, were similar to the scores observed in the duodenum (Figure 6 -C). Sal treated birds had the least severe lesions of those challenged with Eimeria, but not significantly different from the control or BGZn birds (P < 0.0001).
Oocyst Shedding
On days 20-24 (5-9 days post-Eimeria challenge), fecal samples were collected from each challenged pen to determine oocyst shedding as presented in Figure 7 . There was a significant effect of treatment on oocysts shed per pen (P < 0.0001). The BG birds shed significantly more oocysts than Sal birds, while the BGZn and control birds' oocyst counts were not significantly different from any of the challenged groups. The nonchallenge group includes all pens that were not challenged with Eimeria on d 15 and did not have detectable oocysts.
Dual Energy X-Ray Absorptiometry (DXA) and fat pads
On d 28, three birds per pen were processed for DXA analysis where body fat percentage, fat tissue, and lean tissue were measured. Abdominal fat pads were removed and weighed to be included as a supplemental parameter. Figure 8 -A displays DOH to d 28 body fat percentage. No significant interaction was noted between Eimeria challenge and diet (P = 0.8872). However, there was a significant effect of Eimeria challenge on DOH to d 28 body fat percentage (P < 0.0001). The Eimeria-challenged birds had significantly reduced average body fat percentage (18.42%) compared to the non-challenged birds (20.30%). DOH to d 28 average body fat tissue is presented in Figure 8 -B with no significant interaction found between Eimeria challenge and diet (P = 0.2636). Eimeria challenge resulted in reduced body fat tissue (P < 0.0001; 246.40 vs. 197.95 g). Average lean tissue between DOH and d 28 is presented in Figure 8 -C. There was no significant interaction between Eimeria challenge and diet (P = 0.1033), although Eimeria challenge resulted in significantly lower average lean tissue (P < 0.0005; 1085.29 vs. 1163.23 g). There was no significant interaction found between Eimeria challenge and diet on average fat pad weight (Figure 8 -D, P < 0.0935). The Eimeria challenge resulted in significantly lower average fat pad weights (P < 0.0267; 13.35 vs. 14.84 g).
DISCUSSION
The objective of this study was to evaluate the feeding effects of β-glucans, Algamune AM and Algamune ZPC, on performance and response of DOH-28 day-old-broiler chickens during a coccidiosis challenge. Based on the lesion scores and oocyst shedding, it is evident that coccidiosis was successfully induced. The results indicate that average BW for d 21 and d 28 was significantly affected by both Eimeria challenge and β-glucan supplementation, with the Eimeriachallenged birds having considerably lower BW overall than the non-challenged birds. These results are not surprising based on present knowledge and the nature of Eimeria infection (Shirley et al., 2007) . When birds are infected with Eimeria, they can experience reduced feed utilization and poor nutrient absorption in the small intestine leading to decreased weight gains (Williams, 1999) . Interestingly, the non-challenged control groups on d 21 and d 28 were both comparable to the non-challenged BG and Sal groups. As for BWG, the results were fairly similar on d 14 to d 21 and d 21 to d 28. The non-challenged control group was comparable to the three other non-challenged groups, suggesting that supplementation of β-glucans and Salinomycin did not significantly affect BWG. Eimeriachallenged birds had BWG similar across the four challenged groups within each growth period, except for the control during d21-28. The non-challenge control and BG groups had higher BWG, which were Figure 8 . Effect of dietary supplementation of β-glucans on d 28 average fat pad weights of Cobb 500 male broilers. Data are presented as least square means + SEM. Non-chall = non-challenged (Eimeria); Control = challenged with no β-glucan; BG = β-glucan without zinc; BGZn = β-glucan with zinc; Sal = Salinomycin numerically greater than Sal. These results suggest that Eimeria challenge did not impact BWG as much as in some previous studies and β-glucan supplementation did not negatively affect BWG in broilers. Similar results were reported for no-challenge models conducted by Cheng et al. (2004) and Morales-Lopez et al. (2009) . There were also similar results reported in challenged models (Chen et al., 2008) . The coccidiosis challenge as a main effect reduced FI thus worsening FCR, demonstrating its harmful effects on performance. Lower mortality was observed in the Sal and BGZn treatment groups overall, suggesting that smaller birds were surviving longer and contributing less to average FI and BWG, which significantly affected the FCR data. These birds may have been recovering from the coccidiosis challenge over time, but were not contributing enough by the end of the four weeks to substantially add comparable BWG. Barberis et al. (2015) found that the mortality rate decreased with Alphamune R (beta-glucans and oligosaccharides of yeast derivatives) in the Eimeria challenged broiler chickens (1%) compared to the control group (8%).
Previous studies have reported varying results debating the effects of β-glucans on performance in poultry. Zhang et al. (2008) found that β-glucans derived from the yeast S. cerevisiae at 50 and 75 mg/kg in the diet significantly increased BW and BWG. Van Immerseel et al. (2000) reported that Alphamune increased BW and feed efficiency, and improved immune response and reduced Salmonella colonization in chickens. In a comparable work, Rathgeber et al. (2008) observed higher BW in broilers fed β-glucan during the grower phase of production. In addition, yeast cell wall extracts are effective in preventing performance decline in broiler chickens challenged with coccidial oocysts and Clostridium perfringens (Thanissery et al., 2010; Yitbarek et al., 2012; M'Sadeq et al., 2015; ) . Recently, birds fed yeast β-glucan supplemented diet had significantly increased body weight (d 13-21, d 0-42) , improved feed efficiency (d 13-21, d 21-42) , and could prevent loss in body weight gain that is caused by necrotic enteritis (Tian et al., 2016) . In contrast, others reported reduced performance after β-glucan supplementation in chickens (Huff et al., 2006) . These results could be due to reallocation of energy toward immune responses resulting in inefficient nutrient utilization for advancing growth. Correlating with our findings, several cases reported no significant effects of β-glucans on growth performance, suggesting that β-glucans do not negatively affect performance in either no-challenge (Chae et al., 2006; Morales-Lopez et al., 2009; Cox et al., 2010a) or challenge settings (Chen et al., 2006 (Chen et al., , 2008 . The inconsistent results found in those studies could be attributed to a variety of reasons such as differences in the source of the β-glucan, the presence and type of challenge used, or both. As such, further research is required to pinpoint the optimal dosage of β-glucan supplementation for consistent favorable results in poultry. Lu et al. (2014) found that the lack of improved beneficial effect of Alphamune on performance of Eimeria-challenged broiler chickens might be indicative of an overall optimum health of the birds.
To further understand the performance data, an in depth analysis of the Dual Energy X-Ray Absorptiometry (DXA) can be used. It is evident from the DXA results that body fat and lean tissue were reduced in the challenged groups, indicating that these birds may have been allocating more energy to immune processes in response to enteric infection instead of performance enhancement. These results are concurrent with previously reported studies (Allen and Fetterer, 2002; Dalloul and Lillehoj, 2005) , where large differences in growth were observed in infected birds. The lesion scores observed in this study were consistent with previous research using similar inoculation schemes (Ritzi et al., 2014 (Ritzi et al., , 2016 . They were generally low as expected with the numbers of administered oocysts, indicating that the birds were affected by the Eimeria challenge, but then were able to recover over the period following the inoculation. The duodenum was the site of the most severe lesion scores, caused by E. acervulina, when compared to the two other sites sampled. Less severe lesion scores indicate that the intestinal epithelium was less damaged and is still capable of recovering from the infection, resulting in minimal effects on feed utilization and nutrient absorption. Fewer oocysts shed in the feces is also indicative of a healthier gut and suggests that birds in the Sal group showed greater resistance to the Eimeria infection, when compared to the three other Eimeria-challenged groups. Barberis et al. (2015) found that the gross lesion scores and number of oocysts per gram of excreta in the control group were higher than the Alphamune birds with E. acervulina and E. maxima infection. Shanmugasundaram et al. (2013) confirmed that whole yeast cell product decreased the fecal coccidial oocyst counts during Eimeria challenge with significantly increased macrophage nitric oxide and expression of inflammatory cytokine RNA.
Overall, the Salinomycin treatments reduced the 28-day mortality and increased total body weights of the birds, both of which are considered positive responses to coccidiosis. Inclusion of Algamune ZPC [BGZn] also decreased mortality in the coccidia infected birds and resulted in higher body weights, while the Algamune AM [without zinc-BG] did not affect mortality, body weight gain or feed intake. Perhaps, zinc as an added mineral increases palatability or the extra mineral content was more beneficial for the immune system (Wintergerst et al., 2006) . However, birds supplemented with Algamune AM did have lower FCR. It is unclear whether the immunological effects of the β-glucan supplementation or its characteristics as a prebiotic are responsible for the positive effects on performance. Other studies have concluded that prebiotic addition to feed can improve BWG and FCR in chickens (Kabir et al., 2004; Apata, 2008) . Another study found that the dietary supplementation of β-glucan can improve the survival of probiotic bacteria (Rosburg et al., 2010) , suggesting that prebiotic supplements can improve the health of an individual organism. RakoffNahoum et al. (2004) demonstrated the importance of gastrointestinal microbiota on the protection of the epithelial layer of the GI tract. To the best of our knowledge, this is among the first studies to examine effects of adding linear β-glucans to feed in an Eimeria challenge model; as such, comparing our results is difficult. Although the majority of current research is focused on branch-chained β-glucans, most find that glucan supplementation does not hinder performance or negatively affect the bird's health (Cox et al., 2010b) . The β-glucan supplementation had no negative effects on performance nor did it increase mortality. The results of this experiment are promising, though there is a need for further research to determine more effective dosages that would enhance immunity and positively affect performance.
